NM_000497.4(CYP11B1):c.1181del (p.Asn394fs) AND not provided

Germline classification:: Pathogenic (2 submissions)
Last evaluated:: May 31, 2023
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000518608.6

Allele description [Variation Report for NM_000497.4(CYP11B1):c.1181del (p.Asn394fs)]

NM_000497.4(CYP11B1):c.1181del (p.Asn394fs)

Genes:

LOC106799833:CYP11B1 recombination region [Gene]
CYP11B1:cytochrome P450 family 11 subfamily B member 1 [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

8q24.3

Genomic location:

Preferred name:

NM_000497.4(CYP11B1):c.1181del (p.Asn394fs)

HGVS:

NC_000008.11:g.142875254del
NG_007954.1:g.9568del
NG_046132.1:g.1121del
NM_000497.4:c.1181delMANE SELECT
NM_001026213.1:c.1181del
NP_000488.3:p.Asn394fs
NP_001021384.1:p.Asn394fs
NC_000008.10:g.143956669del
NC_000008.10:g.143956670del
NM_000497.3:c.1181delA

Protein change:

N394fs

Links:

dbSNP: rs1256580853

NCBI 1000 Genomes Browser:

rs1256580853

Molecular consequence:

NM_000497.4:c.1181del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001026213.1:c.1181del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Gm38590 predicted gene, 38590 [Mus musculus]
Gm38590 predicted gene, 38590 [Mus musculus]
Gene ID:102641995

Gene
Gm38590 AND (alive[prop]) (1)
Gene
Gm46812 predicted gene, 46812 [Mus musculus]
Gm46812 predicted gene, 46812 [Mus musculus]
Gene ID:108168880

Gene
Gm46812 AND (alive[prop]) (1)
Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000613034	Athena Diagnostics	criteria provided, single submitter (Athena Diagnostics Criteria)	Pathogenic (Oct 11, 2013)	germline	clinical testing	PubMed (2) [See all records that cite these PMIDs] 10487675, 26467025
SCV002244480	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Pathogenic (May 31, 2023)	germline	clinical testing	PubMed (4) [See all records that cite these PMIDs] 10487675, 8506298, 26476331, 28492532

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000613034

Athena Diagnostics

criteria provided, single submitter

(Athena Diagnostics Criteria)

Pathogenic
(Oct 11, 2013)

germline

clinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV002244480

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Pathogenic
(May 31, 2023)

germline

clinical testing

PubMed (4)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]

PMID:: 26467025
PMCID:: PMC4737317

Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.

Cerame BI, Newfield RS, Pascoe L, Curnow KM, Nimkarn S, Roe TF, New MI, Wilson RC.

J Clin Endocrinol Metab. 1999 Sep;84(9):3129-34.

PubMed [citation]

PMID:: 10487675

See all PubMed Citations (5)

Details of each submission

From Athena Diagnostics, SCV000613034.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (2)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002244480.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 447222). This variant is also known as R394del1. This premature translational stop signal has been observed in individual(s) with congenital adrenal hyperplasia (PMID: 10487675). This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Asn394Thrfs*36) in the CYP11B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP11B1 are known to be pathogenic (PMID: 8506298, 26476331).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine